According to the Zhongxin Pharmaceutical Group in this city, the Shuxinxin Pills from Tianjin No. 6 Chinese Medicine Factory, which was designated as a major scientific and technological project, have finally been successfully developed after two decades of research and are now shaping the future of the city's pharmaceutical industry. As a key product in the development strategy of traditional Chinese medicine, the factory has invested 100 million yuan to introduce advanced supercritical extraction equipment. This modern workshop for drop pills has played a crucial role in applying supercritical extraction technology to the production of drop pills, helping the city establish itself as a national center for large-scale, high-tech pharmaceutical manufacturing.
This year, the city has launched a strategic plan to accelerate the growth of its high-tech biotechnology and pharmaceutical sectors, with targeted measures in place to achieve an annual sales revenue of 27 billion yuan, representing a 23% year-on-year increase. This initiative is set to become a new economic driver, elevating Tianjin’s overall strength in biotechnology and pharmaceuticals to a national level. Among the key projects under this strategy is the Shuxinxin Drop Pills, officially recognized by national authorities and experts as a traditional Chinese medicine drop pill used for treating cerebrovascular diseases. Drawing on the ancient formula "Zigui Tang," the drug integrates modern international techniques to extract and produce high-yield pellets, becoming a sister product to "Quick Saving Heart Pills." It offers three key benefits: clearing the brain, nourishing it, and protecting it. The launch of this product marks a significant step forward in upgrading the city's high-tech biotech and pharmaceutical industry strategy.
**Word count: 504**Frozen Swimming Crab,Crab Frozen,Frozen Cut Swimming Crab,Blue Swimming Crab
Zhoushan City Shuangying Aquatic Products Co., Ltd.  , https://www.shuangying-aquatic.com